Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artículo
|
![]() |
eEF2K: an atypical kinase target for cancerTemme, Louisa ; Asquith, Christopher R. MNature reviews. Drug discovery, 2021-08, Vol.20 (8), p.577-577 [Revista revisada por pares]London: Nature Publishing GroupTexto completo disponible |
2 |
Material Type: Artículo
|
![]() |
PIKfyve: a lipid kinase target for COVID-19, cancer and neurodegenerative disordersHuang, Pei-Tzu ; Einav, Shirit ; Asquith, Christopher R. MNature reviews. Drug discovery, 2021-10, Vol.20 (10), p.730-730 [Revista revisada por pares]London: Nature Publishing GroupTexto completo disponible |
3 |
Material Type: Artículo
|
![]() |
BCKDK: an emerging kinase target for metabolic diseases and cancerEast, Michael P ; Laitinen, Tuomo ; Asquith, Christopher R. MNature reviews. Drug discovery, 2021-07, Vol.20 (7), p.498-498 [Revista revisada por pares]London: Nature Publishing GroupTexto completo disponible |
4 |
Material Type: Artículo
|
![]() |
PKMYT1: a forgotten member of the WEE1 familyAsquith, Christopher R M ; Laitinen, Tuomo ; East, Michael PNature reviews. Drug discovery, 2020-03, Vol.19 (3), p.157-157 [Revista revisada por pares]England: Nature Publishing GroupTexto completo disponible |
5 |
Material Type: Artículo
|
![]() |
Utilization of Supervised Machine Learning to Understand Kinase Inhibitor Toxophore ProfilesBieberich, Andrew A ; Asquith, Christopher R MInternational journal of molecular sciences, 2023-03, Vol.24 (6), p.5088 [Revista revisada por pares]Switzerland: MDPI AGTexto completo disponible |
6 |
Material Type: Artículo
|
![]() |
STK19: a new target for NRAS-driven cancerAsquith, Christopher R. M ; Temme, LouisaNature reviews. Drug discovery, 2020-09, Vol.19 (9), p.579-579 [Revista revisada por pares]London: Nature Publishing GroupTexto completo disponible |
7 |
Material Type: Artículo
|
![]() |
The Synthesis and Biological Applications of the 1,2,3-Dithiazole ScaffoldKalogirou, Andreas S ; Oh, Hans J ; Asquith, Christopher R MMolecules (Basel, Switzerland), 2023-04, Vol.28 (7), p.3193 [Revista revisada por pares]Switzerland: MDPI AGTexto completo disponible |
8 |
Material Type: Artículo
|
![]() |
PIP5K1A: a potential target for cancers with KRAS or TP53 mutationsEast, Michael P ; Laitinen, Tuomo ; Asquith, Christopher R MNature reviews. Drug discovery, 2020-07, Vol.19 (7), p.436-436 [Revista revisada por pares]England: Nature Publishing GroupTexto completo disponible |
9 |
Material Type: Artículo
|
![]() |
WNK kinases: an untapped opportunity to modulate ion transportEast, Michael P ; Laitinen, Tuomo ; Asquith, Christopher R MNature reviews. Drug discovery, 2020-12, Vol.19 (12), p.828-828 [Revista revisada por pares]England: Nature Publishing GroupTexto completo disponible |
10 |
Material Type: Artículo
|
![]() |
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in ChordomaAsquith, Christopher R. M ; Naegeli, Kaleb M ; East, Michael P ; Laitinen, Tuomo ; Havener, Tammy M ; Wells, Carrow I ; Johnson, Gary L ; Drewry, David H ; Zuercher, William J ; Morris, David CJournal of medicinal chemistry, 2019-05, Vol.62 (9), p.4772-4778 [Revista revisada por pares]United States: American Chemical SocietyTexto completo disponible |